The agency flagged several violations at a compounding pharmacy owned by Hims & Hers, including “infestation by rodents, ...

Q4 2025 earnings call recap: record $44B backlog, strong cash flow, and 2026 outlook for 20%+ EPS growth—read now.

HydroGraph expands Compounding Partner Program with UK-based Hubron International to boost graphene-enhanced thermoplastics ...

Detailed price information for Taiwan Semiconductor ADR (TSM-N) from The Globe and Mail including charting and trades.

Shares of NVO are on the move again premarket, soaring another 7% on the news, while HIMS shares are down 16% in early trading. However, questions continue to surface about cheaper medication ...

Dave Evans argues that North America’s next manufacturing boom will be defined by speed, resilience, and systems built for ...

The project is being set up by Vamasundari Investments Pvt Ltd, a joint venture between HCL Group and Foxconn ...

The chemical industry is valued at between $800 and $900 billion, and it is also the backbone of the US industrial sector.

This company has been recognized locally and nationally for revenue and employment growth, but now it's making some cuts.

Online telehealth company Hims & Hers Health, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a risky ...